1530.HK
Price:
$11.16
Market Cap:
$24.40B
3SBio Inc., an investment holding company, researches, develops, manufactures, markets, and sells biopharmaceutical products in the People's Republic of China. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; YISAIPU, a tumor necrosis factor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis; EPIAO and SEPO recombinant human erythropoietins to treat anemia; and Cipterbin for HER2-positive metastatic breast cancer in combination with chemotherapy. It also offers Mandi to treat male alopecia and alopecia areata; Xenopax for preventing acute rejection after renal transplant; Byetta for the glycemi...[Read more]
Industry
Biotechnology
IPO Date
2015-06-11
Stock Exchange
HKSE
Ticker
1530.HK
According to 3SBio Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 12.26. This represents a change of 159.80% compared to the average of 4.72 of the last 4 quarters.
The mean historical PE Ratio of 3SBio Inc. over the last ten years is 19.77. The current 12.26 PE Ratio has changed 6.10% with respect to the historical average. Over the past ten years (40 quarters), 1530.HK's PE Ratio was at its highest in in the December 2013 quarter at 199.66. The PE Ratio was at its lowest in in the December 2004 quarter at 0.
Average
19.77
Median
19.29
Minimum
6.72
Maximum
39.02
Discovering the peaks and valleys of 3SBio Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 52.87%
Maximum Annual PE Ratio = 39.02
Minimum Annual Increase = -56.24%
Minimum Annual PE Ratio = 6.72
Year | PE Ratio | Change |
---|---|---|
2024 | 6.72 | -38.43% |
2023 | 10.91 | 10.70% |
2022 | 9.86 | 15.05% |
2021 | 8.57 | -56.24% |
2020 | 19.58 | -16.67% |
2019 | 23.49 | 23.65% |
2018 | 19.00 | -48.07% |
2017 | 36.59 | 52.87% |
2016 | 23.94 | -38.66% |
2015 | 39.02 | -21.43% |
The current PE Ratio of 3SBio Inc. (1530.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
9.16
5-year avg
11.13
10-year avg
19.77
3SBio Inc.’s PE Ratio is less than Luye Pharma Group Ltd. (14.44), greater than Genscript Biotech Corporation (-15.96), less than Livzon Pharmaceutical Group Inc. (15.11), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (21.39), greater than China Resources Medical Holdings Company Limited (7.79),
Company | PE Ratio | Market cap |
---|---|---|
14.44 | $7.34B | |
-15.96 | $22.28B | |
15.11 | $30.98B | |
21.39 | $61.53B | |
7.79 | $4.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 3SBio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 3SBio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 3SBio Inc.'s PE Ratio?
How is the PE Ratio calculated for 3SBio Inc. (1530.HK)?
What is the highest PE Ratio for 3SBio Inc. (1530.HK)?
What is the 3-year average PE Ratio for 3SBio Inc. (1530.HK)?
What is the 5-year average PE Ratio for 3SBio Inc. (1530.HK)?
How does the current PE Ratio for 3SBio Inc. (1530.HK) compare to its historical average?